AbbVie Receives CHMP Positive Opinion for Upadacitinib (RINVOQ™) for the Treatment of Adults with Active Rheumatoid Arthritis

(STL.News) – AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the European Medicines…

AbbVie Announces Data from Dermatology Portfolio and Pipeline at the 28th European Academy of Dermatology and Venereology (EADV) Congress

North Chicago, Ill., (STL.News) – AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that it…

AbbVie to Host Third-Quarter 2019 Earnings Conference Call

North Chicago, Ill., (STL.News) – AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its…